Published in Proc Natl Acad Sci U S A on March 15, 1994
Kinetic discrimination in T-cell activation. Proc Natl Acad Sci U S A (1996) 2.17
Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med (1997) 1.49
Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med (1996) 1.48
Sensitivity of T cells to antigen and antagonism emerges from differential regulation of the same molecular signaling module. Proc Natl Acad Sci U S A (2007) 1.43
Purely stochastic binary decisions in cell signaling models without underlying deterministic bistabilities. Proc Natl Acad Sci U S A (2007) 1.42
A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. J Exp Med (1999) 1.36
Th2 cell clonal anergy as a consequence of partial activation. J Exp Med (1994) 1.34
Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med (1995) 1.31
Stochastic effects and bistability in T cell receptor signaling. J Theor Biol (2008) 1.17
Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation. J Exp Med (1999) 1.16
Modulation of T cell development by an endogenous altered peptide ligand. J Exp Med (1995) 1.08
Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J Exp Med (1996) 1.07
Endogenous altered peptide ligands can affect peripheral T cell responses. J Exp Med (1996) 1.01
Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology. Front Immunol (2013) 0.93
F(c)gammaRI-targeted fusion proteins result in efficient presentation by human monocytes of antigenic and antagonist T cell epitopes. J Clin Invest (1996) 0.88
Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands. Eur J Immunol (2008) 0.77
Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas. J Immunol Methods (2015) 0.75
A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function. Retrovirology (2014) 0.75
Computational analysis of T cell receptor signaling and ligand discrimination--past, present, and future. FEBS Lett (2010) 0.75
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science (1990) 12.13
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Contingent genetic regulatory events in T lymphocyte activation. Science (1989) 8.03
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell (1989) 7.02
T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol (1985) 6.98
Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol (1991) 5.71
Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature (1992) 4.01
T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med (1988) 3.90
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
Superantigens interact with MHC class II molecules outside of the antigen groove. Cell (1990) 3.20
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today (1993) 2.91
Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature (1992) 2.84
Two better cell lines for making hybridomas expressing specific T cell receptors. J Immunol (1989) 2.78
Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature (1990) 2.60
Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med (1993) 2.57
Cell growth cycle block of T cell hybridomas upon activation with antigen. J Exp Med (1987) 2.30
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell (1993) 2.11
The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells. Immunol Rev (1986) 1.81
The thymus selects the useful, neglects the useless and destroys the harmful. Immunol Today (1989) 1.54
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol (1993) 1.40
CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J Exp Med (1992) 1.36
Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants. Science (1990) 1.36
Activation-driven programmed cell death and T cell receptor zeta eta expression. Science (1989) 1.27
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J Immunol (1992) 1.24
Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events. Proc Natl Acad Sci U S A (1993) 1.21
Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells. J Immunol (1988) 1.17
Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways. Proc Natl Acad Sci U S A (1991) 1.12
T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues. J Immunol (1993) 1.08
T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci U S A (1992) 0.93
Selective induction of growth factor production and growth factor receptor expression by different signals to a single T cell. Eur J Immunol (1989) 0.80
The immunological synapse: a molecular machine controlling T cell activation. Science (1999) 17.41
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell (1996) 7.81
LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell (1998) 6.15
The basis for the immunoregulatory role of macrophages and other accessory cells. Science (1987) 4.51
The immunological synapse. Annu Rev Immunol (2001) 4.45
Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol (2001) 4.39
A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell (1998) 4.21
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (1993) 3.83
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell (1994) 3.71
Antigen presentation: comments on its regulation and mechanism. J Immunol (1984) 3.68
Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol (1996) 3.59
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58
Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol (1984) 3.41
Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature (1987) 3.08
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum (2010) 2.99
Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today (1993) 2.91
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity (1998) 2.49
Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas. Proc Natl Acad Sci U S A (1984) 2.40
Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23
Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol (1991) 2.20
Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 2.13
14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity. Mol Cell Biol (1998) 2.07
A novel member of the integrin receptor family mediates Arg-Gly-Asp-stimulated neutrophil phagocytosis. J Cell Biol (1989) 1.95
Essential flexibility in the T-cell recognition of antigen. Nature (1996) 1.86
Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity (1995) 1.80
Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. J Immunol (1985) 1.67
Altered T cell receptor ligands trigger a subset of early T cell signals. Immunity (1996) 1.64
Structural and functional consequences of altering a peptide MHC anchor residue. J Immunol (2001) 1.51
Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A (1991) 1.49
Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med (1997) 1.49
Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med (1996) 1.48
Direct evidence for functional self-protein/Ia-molecule complexes in vivo. Proc Natl Acad Sci U S A (1988) 1.48
Proline residues in CD28 and the Src homology (SH)3 domain of Lck are required for T cell costimulation. J Exp Med (1999) 1.44
Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism. Proc Natl Acad Sci U S A (1989) 1.40
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J Immunol (1993) 1.40
A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata. Br J Cancer (1973) 1.39
A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. J Exp Med (1999) 1.36
Th2 cell clonal anergy as a consequence of partial activation. J Exp Med (1994) 1.34
Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med (1995) 1.31
Direct evidence that a class II molecule and a simple globular protein generate multiple determinants. J Exp Med (1985) 1.29
T cell recognition of fibrinogen. A determinant on the A alpha-chain does not require processing. J Immunol (1988) 1.27
Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria. Mol Microbiol (1996) 1.27
Binding to Ia protects an immunogenic peptide from proteolytic degradation. J Immunol (1989) 1.24
Complete dissection of the Hb(64-76) determinant using T helper 1, T helper 2 clones, and T cell hybridomas. J Immunol (1992) 1.24
Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J Immunol (2000) 1.24
The handling of Listeria monocytogenes by macrophages: the search for an immunogenic molecule in antigen presentation. J Immunol (1984) 1.20
Thymic cortical epithelial cells lack full capacity for antigen presentation. Nature (1989) 1.18
Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation. J Exp Med (1999) 1.16
Comment on the finding of Ia expression in nonlymphoid cells. Lab Invest (1986) 1.16
Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res (1992) 1.16
TCR transgenic mice in which usage of transgenic alpha- and beta-chains is highly dependent on the level of selecting ligand. J Immunol (1998) 1.14
Thymic cortical epithelial cells can present self-antigens in vivo. Nature (1989) 1.13
The mode of action of lincomycin. Biochem Biophys Res Commun (1964) 1.10
Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci U S A (1992) 1.09
Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP. J Biol Chem (1999) 1.08
Modulation of T cell development by an endogenous altered peptide ligand. J Exp Med (1995) 1.08
T cell receptor gene segment usage in a panel of hen-egg white lysozyme specific, I-Ak-restricted T helper hybridomas. J Immunol (1989) 1.07
Identification and characterization of a T cell-inducing epitope of bovine ribonuclease that can be restricted by multiple class II molecules. J Immunol (1991) 1.06
Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr Opin Immunol (1995) 1.05
TCR-independent pathways mediate the effects of antigen dose and altered peptide ligands on Th cell polarization. J Immunol (1999) 1.04
In vivo antagonism of a T cell response by an endogenously expressed ligand. Proc Natl Acad Sci U S A (1998) 1.04
Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol (1992) 1.02
Selective activation of the calcium signaling pathway by altered peptide ligands. J Exp Med (1996) 1.02
Endogenous altered peptide ligands can affect peripheral T cell responses. J Exp Med (1996) 1.01
Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype. J Immunol (1997) 1.01
Environmental control of immunological synapse formation and duration. Trends Immunol (2001) 1.01
Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules. Proc Natl Acad Sci U S A (1988) 1.00
A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity (1998) 1.00
Darwinian evolution and a predator--prey ecology. Bull Math Biol (1975) 0.98
Development of a novel strategy for engineering high-affinity proteins by yeast display. Protein Eng Des Sel (2006) 0.98
Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy: a phase II, randomized, placebo-controlled trial. Arthritis Rheum (2013) 0.96
T cell recognition of bovine ribonuclease. Self/non-self discrimination at the level of binding to the I-Ak molecule. J Immunol (1988) 0.96
Antigen processing and presentation by macrophages. Am J Anat (1984) 0.95
Intramolecular mimicry. Identification and analysis of two cross-reactive T cell epitopes within a single protein. J Immunol (1995) 0.95
Cutting edge: the tyrosine phosphatase SHP-1 regulates thymocyte positive selection. J Immunol (1999) 0.93
Differential requirements for CD4 in TCR-ligand interactions. J Immunol (1999) 0.93
Kissing cousins: immunological and neurological synapses. Nat Immunol (2001) 0.92
Reconstruction of the immunogenic peptide RNase(43-56) by identification and transfer of the critical residues into an unrelated peptide backbone. J Exp Med (1989) 0.91
In vivo expression of a TCR antagonist: T cells escape central tolerance but are antagonized in the periphery. J Immunol (1998) 0.91
The role of T cells in myosin-induced autoimmune myocarditis. Clin Immunol Immunopathol (1993) 0.89
Bone marrow-derived macrophage as accessory cells in antigen-induced T cell proliferation. H-2I region requirements for L-glutamic60-L-alanine30-L-tyrosine10 response. J Immunol (1983) 0.89
Processing and presentation of self proteins. Immunol Rev (1988) 0.88
TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity. J Immunol (1996) 0.87
Constitutive competition by self proteins for antigen presentation can be overcome by receptor-enhanced uptake. J Immunol (1990) 0.86
Hen egg-white lysozyme-specific T cells elicited in hen egg-white lysozyme-transgenic mice retain an imprint of self-tolerance. J Immunol (1993) 0.86
Biochemistry and biology of antigen presentation by macrophages. Cell Immunol (1986) 0.86
Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands. J Immunol (1998) 0.85
Genetically separable determinants of hair keratin gene expression. Dev Dyn (2000) 0.85
Promethean viruses? Nature (1994) 0.84
Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells. Thromb Haemost (2001) 0.84
Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture. J Immunol (2000) 0.84
Mechanism of action of the fungicide thiabendazole, 2-(4'-thiazolyl) benzimidazole. Appl Microbiol (1970) 0.82